Jack A. Khattar - Oct 2, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Oct 2, 2025
Transactions value $
-$708,168
Form type
4
Date filed
10/3/2025, 04:19 PM
Previous filing
Oct 2, 2025
Next filing
Oct 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Khattar Jack A. President, CEO, Director C/O SUPERNUS PHARMACEUTICALS INC., 9715 KEY WEST AVENUE, ROCKVILLE /s/ Timothy C. Dec, as attorney-in-fact 2025-10-03 0001539937

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +20K +1.72% $0.00 1.18M Oct 2, 2025 Direct F1
transaction SUPN Common Stock Tax liability -$360K -7.8K -0.66% $46.21 1.17M Oct 2, 2025 Direct F2
transaction SUPN Common Stock Options Exercise $0 +19.3K +1.65% $0.00 1.19M Oct 2, 2025 Direct F3
transaction SUPN Common Stock Tax liability -$348K -7.53K -0.63% $46.21 1.19M Oct 2, 2025 Direct F2
holding SUPN Common Stock 1.01M Oct 2, 2025 By the KBT Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -20K -100% $0.00 0 Oct 2, 2025 Common Stock 20K $0.00 Direct F4
transaction SUPN Performance Share Units Options Exercise $0 -19.3K -100% $0.00 0 Oct 2, 2025 Common Stock 19.3K $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 19, 2021.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
F3 Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
F4 On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021.
F5 On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.